A prospective cancer chemo-immunotherapy approach mediated by synergistic CD326 targeted porous silicon nanovectors

Chitosan-modified porous silicon microparticles for enhanced permeability of insulin across intestinal cell monolayers

(2014) Neha Shrestha et al.   BIOMATERIALS

Augmented cellular trafficking and endosomal escape of porous silicon nanoparticles via zwitterionic bilayer polymer surface engineering

(2014) Mohammad-Ali Shahbazi et al.   BIOMATERIALS

Development of immunomonitoring of antibody-dependent cellular cytotoxicity against neuroblastoma cells using whole blood

(2014) Ferdousi Chowdhury et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Poly(methyl vinyl ether-alt-maleic acid)-Functionalized Porous Silicon Nanoparticles for Enhanced Stability and Cellular Internalization

(2014) Mohammad-Ali Shahbazi et al.   MACROMOLECULAR RAPID COMMUNICATIONS

Simultaneous Inhibition of Tumor Growth and Angiogenesis for Resistant Hepatocellular Carcinoma by Co-delivery of Sorafenib and Survivin Small Hairpin RNA

(2014) Jianan Shen et al.   MOLECULAR PHARMACEUTICS

Assessing the In Vivo Targeting Efficiency of Multifunctional Nanoconstructs Bearing Antibody-Derived Ligands

(2013) Luisa Fiandra et al.   ACS Nano

Anti-CD30 antibody conjugated liposomal doxorubicin with significantly improved therapeutic efficacy against anaplastic large cell lymphoma

(2013) Ommoleila Molavi et al.   BIOMATERIALS

The mechanisms of surface chemistry effects of mesoporous silicon nanoparticles on immunotoxicity and biocompatibility

(2013) Mohammad-Ali Shahbazi et al.   BIOMATERIALS

Polycation-functionalized nanoporous silicon particles for gene silencing on breast cancer cells

(2013) Mingzhen Zhang et al.   BIOMATERIALS

Targeted therapy of brain ischaemia using Fas ligand antibody conjugated PEG-lipid nanoparticles

(2013) Ying-mei Lu et al.   BIOMATERIALS

Porous Silicon–Cell Penetrating Peptide Hybrid Nanocarrier for Intracellular Delivery of Oligonucleotides

(2013) Jussi Rytkönen et al.   MOLECULAR PHARMACEUTICS

Development of drug loaded nanoparticles for tumor targeting. Part 1: synthesis, characterization, and biological evaluation in 2D cell cultures

(2013) Mohammad H. El-Dakdouki et al.   Nanoscale

Multistage Vectored siRNA Targeting Ataxia-Telangiectasia Mutated for Breast Cancer Therapy

(2013) Rong Xu et al.   Small

Natural Killer Cell Mediated Antibody-Dependent Cellular Cytotoxicity in Tumor Immunotherapy with Therapeutic Antibodies

(2013) Ursula J. E. Seidel et al.   Frontiers in Immunology

Multivalent Porous Silicon Nanoparticles Enhance the Immune Activation Potency of Agonistic CD40 Antibody

(2012) Luo Gu et al.   ADVANCED MATERIALS

Phenotype-dependent effects of EpCAM expression on growth and invasion of human breast cancer cell lines

(2012) Agnieszka Martowicz et al.   BMC CANCER

Functionalized mesoporous silicon for targeted-drug-delivery

(2012) Ozra Tabasi et al.   COLLOIDS AND SURFACES B-BIOINTERFACES

Analysis on the current status of targeted drug delivery to tumors

(2012) Il Keun Kwon et al.   JOURNAL OF CONTROLLED RELEASE

Targeted drug delivery for cancer therapy: the other side of antibodies

(2012) Michael A Firer et al.   Journal of Hematology & Oncology

Nanostructured porous silicon in preclinical imaging: Moving from bench to bedside

(2012) Hélder A. Santos et al.   JOURNAL OF MATERIALS RESEARCH

Antibody-Functionalized Porous Silicon Nanoparticles for Vectorization of Hydrophobic Drugs

(2012) Emilie Secret et al.   Advanced Healthcare Materials

Ambient temperature synthesis of citrate stabilized and biofunctionalized, fluorescent calcium fluoridenanocrystals for targeted labeling of cancer cells

(2012) Sisini Sasidharan et al.   Biomaterials Science

Thermally promoted addition of undecylenic acid on thermally hydrocarbonized porous silicon optical reflectors

(2012) Tero Jalkanen et al.   Nanoscale Research Letters

Noncovalent Functionalization of Carbon Nanovectors with an Antibody Enables Targeted Drug Delivery

(2011) Jacob M. Berlin et al.   ACS Nano

Quantitative control of targeting effect of anticancer drugs formulated by ligand-conjugated nanoparticles of biodegradable copolymer blend

(2011) Jing Zhao et al.   BIOMATERIALS

Targeted chemoimmunotherapy using drug-loaded aptamer–dendrimer bioconjugates

(2011) In-Hyun Lee et al.   JOURNAL OF CONTROLLED RELEASE

Cetuximab-labeled liposomes containing near-infrared probe for in vivo imaging

(2011) Emma Portnoy et al.   Nanomedicine-Nanotechnology Biology and Medicine

Antibody Covalent Immobilization on Carbon Nanotubes and Assessment of Antigen Binding

(2011) Enrica Venturelli et al.   Small

Synthesis of Biomolecule-Modified Mesoporous Silica Nanoparticles for Targeted Hydrophobic Drug Delivery to Cancer Cells

(2011) Daniel P. Ferris et al.   Small

EPR effect based drug design and clinical outlook for enhanced cancer chemotherapy

(2010) Hiroshi Maeda et al.   ADVANCED DRUG DELIVERY REVIEWS

A strategy for precision engineering of nanoparticles of biodegradable copolymers for quantitative control of targeted drug delivery

(2010) Yutao Liu et al.   BIOMATERIALS

To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery

(2010) Fabienne Danhier et al.   JOURNAL OF CONTROLLED RELEASE

Investigating the structural biofunctionality of antibodies conjugated to magnetic nanoparticles

(2010) Emanuela Occhipinti et al.   Nanoscale

In vitro cytotoxicity of porous silicon microparticles: Effect of the particle concentration, surface chemistry and size

(2009) Hélder A. Santos et al.   Acta Biomaterialia

Monoclonal antibodies for cancer immunotherapy

(2009) Louis M Weiner et al.   LANCET

Active targeting schemes for nanoparticle systems in cancer therapeutics

(2008) James D. Byrne et al.   ADVANCED DRUG DELIVERY REVIEWS